Results 231 to 240 of about 471,297 (330)
Role of Sphingosine-1-Phosphate Signaling Pathway in Pancreatic Diseases. [PDF]
Int J Mol SciFu F, Li W, Zheng X, Wu Y, Du D, Han C.
europepmc +1 more source
IL-17 in pancreatic disease: pathogenesis and pharmacotherapy.
, 2020 Fenglin Hu +6 more
openalex +1 more source
Advanced Science, EarlyView.This study demonstrates that dual UCP2/IL‐17 blockade reprograms T‐cell metabolism to overcome PDAC immunosuppression. Genipin‐mediated UCP2 inhibition enhances CD8⁺ T‐cell IFN‐γ via IL‐12R/STAT4/mTOR signaling and mitochondrial OXPHOS. Combined IL‐17 depletion amplifies Tc1/Th1 responses, reduces MDSCs, and prolongs survival in PDAC models ...
Chuan‐Teng Liu +11 more
wiley +1 more source
Expression and Targeted Application of Claudins Family in Hepatobiliary and Pancreatic Diseases. [PDF]
J Hepatocell CarcinomaDu F, Xie Y, Wu S, Ji M, Dong B, Zhu C.
europepmc +1 more source
Advanced Science, EarlyView.CELLama is created, a framework that harnesses language models to convert cellular data into “sentences” that represent gene expression and metadata, enabling a universal embedding of cells. Unlike most single‐cell foundation models, CELLama supports scalable analysis and offers flexible applications including spatial transcriptomics.
Jeongbin Park +7 more
wiley +1 more source
Protein N-Glycosylation Traits Combined with CA19-9 Accurately Distinguish Pancreatic Cancer Cases From Healthy Controls and Benign Pancreatic Diseases. [PDF]
PancreasBogdanski AM +11 more
europepmc +1 more source
Pancreatic diseases register of the German society for general and visceral surgery
, 2019 Andrey Litvin +3 more
openalex +2 more sources
An evaluation of DUPAN-2 in pancreatic cancer and gastrointestinal disease [PDF]
, 1990 E H Cooper, MA Forbes, Mark Taylor
openalex +1 more source